CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop gold nanoparticles that target specific receptors to deliver therapeutic agents for Parkinson's disease. By utilizing these nanoparticles, the project seeks to inhibit harmful protein aggregation and enhance antioxidant defenses in brain cells, potentially improving treatment outcomes for p…
Parkinson’s disease (PD) is a chronic and debilitating neurodegenerative movement disorder that is set to rise in incidence with a rapidly ageing global population.
As current clinical treatments offer only symptomatic control with no curative options, there is an urgent need for novel therapeutic approaches that can delay further neurodegeneration and enhance the overall quality of life in PD patients.
Recent emerging evidence on the prion-like spreading neuronal accumulation of misfolded α-syn…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
